pharmacology opioids therapeutics

Which of the following statements is false? 2 ptsThe opioid “trigger point” for re-evaluation of appropriateness of opioid treatment of in the Ohio Guidelines for Prescribing Opioids for the Treatment of Chronic, Non-Terminal Pain is 80 mg of a Morphine Equivalent Daily Dose (MEDD)
According to the Ohio Guidelines for Emergency and Care Facilities Opioid and other Controlled Substances (OOCS)Prescribing, except in rare circumstances OOCS prescriptions should be limited to a 4-day supply.
The Ohio Guideline for the Management of Acute Pain Outside of Emergency Departments state that nonpharmacologic and nonopioid treatments should be optimized and a risk assessment and checking OARRS should be done prior to prescribing opioids.
According to the Ohio State Board of Pharmacy (https://www.pharmacy.ohio.gov/Documents/Pubs/Special/ControlledSubstances/For Prescribers – New Limits on Prescription Opioids for Acute Pain.pdf) For adults, a maximum of 30mg Morphine Equivalents Daily (MED) and a duration of 7 days should be the standard for opioid prescribing for acute pain unless the prescriber has documented the reason for going outside these parameters

pharmacology-opioids therapeutics

Which of the following is true with respect to Nonsteroidal anti-inflammatory drugs (NSAIDs) 2ptsOnly preferentially COX 2 inhibitors (e.g. celecoxib) put a patient at risk for a stroke or MI.
Naproxen plus a proton pump inhibitor provides the same gastrointestinal protection as celecoxib without a proton pump inhibitor
Topical Diclofenac should be used four times a day as needed
Because aspirin causes irreversible platelet inhibition, it should be given along with the morning dose of ibuprofen